Abstract
Minimally invasive and robotic cardiac surgery have been developed to reduce surgical trauma, shorten recovery, and improve cosmetic and functional outcomes. However, these approaches often require longer cardiopulmonary bypass (CPB) and aortic cross-clamp times than conventional full sternotomy, and CPB duration remains an independent predictor of postoperative morbidity and mortality, particularly in frail patients with reduced physiological reserve. The resulting less invasive access/prolonged extracorporeal support duration paradox poses a major physiological and clinical challenge. Contemporary evidence from randomized and observational studies reports that while minimally invasive and robotic procedures achieve comparable or improved survival and functional recovery, extended CPB and aortic clamp times can amplify the risk of renal dysfunction, neurological events, and systemic inflammation. Advances in digital health are now transforming intraoperative perfusion management: high-frequency data acquisition, automated oxygen delivery and consumption analytics, and real-time artificial intelligence-driven predictive models enable early detection of perfusion imbalance and metabolic distress. Integration of these data streams within interoperable platforms and patient-specific digital twins may allow dynamic modeling of perfusion adequacy and adaptive control of pump flow, temperature, and hemodynamics. By converting CPB duration from a static procedural metric into a digitally monitored, optimizable variable, precision perfusion could reconcile minimal invasiveness with physiological safety. Future research should validate these digital frameworks in multicenter studies and establish standards for transparency, interoperability, and ethical implementation in real-world cardiac surgery.